The NCMM network meeting will take place on 18-19 January 2016. This meeting is intended for NCMM/BiO group leaders, newly appointed and reappointed NCMM AIs and YAIs, Board members and other stakeholders and scientific leaders. The meeting is planned from lunch-to-lunch.
MSc Kristine Moltu at the Department of Biosciences will be defending the thesis Signal network analysis of T cell activation – in human T cells from blood donors and patients with colorectal cancer for the degree of PhD.
Tomas Brdicka is heading the Laboratory of Leukocyte Signalling at the Institute of Molecular Genetics of the ASCR in Prague, the Czech Republic. The Laboratory of Leukocyte Signalling is studying the molecular mechanisms of signal transduction in leukocytes and his team has recently focused on the interplay between adaptor proteins, Src-family kinases and related kinase Csk. In addition, the group is involved in research aiming at uncovering the relationship between signal transduction and leukocyte-driven pathologies. Projects include studies of signalling proteins aberrantly expressed in childhood leukaemias and research of changes in leukocyte signal transduction in patients with Common Variable ImmunoDeficiency (CVID).
'Regulation of leukocyte signaling by Csk-binding proteins SCIMP and PSTPIP2' is his presentation for the Hans Prydz Guest Lecture series.
Yearly, the Centres arrange a common BiO + NCMM retreat where all employees and students at the centres are invited. Program.
M.Sc. Stefan Jörg Barfeld at the Centre for Molecular Medicine Norway and the Department of Biosciences, Faculty of Mathematics and Natural Sciences will be defending the thesis The transcriptional role of c-Myc in prostate cancer for the degree of PhD. The event will take place on October 23, Kristine Bonnevie Building at 13:15.
The trial lecture entitled "Cancer Immunotherapy - strategies, mechanisms and challenges" takes place on October 23 at 10:15, Nucleus, Bikuben, Kristine Bonnevie Building.
Professor John D. Scott and his group are located at the Howard Hughes Medical Institute, Department of Pharmacology, University of Washington, Seattle, US. The Scott research group is interested in understanding the specificity of signal transduction events that are controlled by anchoring proteins. Anchoring proteins facilitate rapid signal transduction by optimally positioning protein kinases and phosphatases in the vicinity of their activating signals and close to their substrates.
'Guiding signals through anchored enzyme complexes: implications for disease' is his presentation for the Hans Prydz Guest Lecture series.
The 2015 NMMN Meeting will take at Aarhus University on September 8-10.
Dr. Juan Mata is a group leader at Department of Biochemistry, University of Cambridge.
'From the translatome to the small proteomeis' is his presentation for the Hans Prydz Guest Lecture series.
Dr. Danilo Maddalo is a postdoctoral fellow in Andrea Ventura's research group at Memorial Sloan Kettering Cancer Center in New York, US. The research group is exploring the functional relevance of miRNAs and long non-coding RNAs in cancer and development. In parallel, the group is developing and applying novel methods of modeling human cancers in mice using somatic genome editing.
'In vivo chromosomal engineering' is his presentation for the Hans Prydz Guest Lecture series.
Professor Alvis Brazma and his group is located at the European Bioinformatics Institute (EMBL-EBI), Hinxton, Cambridge.
'Transcriptome structure in normal and cancer gene expression' is his presentation for the Hans Prydz Guest Lecture series.
On Tuesday the 24th of February Tanima SenGupta from Hilde Nilsen’s research group will defend her PhD thesis: Chemical genetic studies in Caenorhabditis elegans reveal genome dynamics as key factor in response to chemotherapeutic agents.
Petr Bartunek is group leader at the Institute of Molecular Genetics (IMG) in Prague and Director of CZ-OPENSCREEN: National Infrastructure for Chemical Biology. His research is focused on understanding molecular mechanism of cell fate determination. They use growth factors and small molecules to manipulate processes of hematopoietic and neural stem cell self-renewal and differentiation. More recently, they have pioneered ex vivo hematopoietic cell culture techniques in zebrafish that enable analysis of normal and leukemic hematopoiesis. The title of his talk is “Dissecting blood development using zebrafish”.
Professor Olivier Poetz is employed at The Natural and Medical Sciences Institute (NMI) at the University of Tübingen and his lecture is titled 'Immunoassays: High Sensitivity, High Specificity, High Speed for, any Type of Analyte, and Clinical Specimen'
Professor Anders Sundan is heading the K.G. Jebsen Center for Myeloma Research that was established at the Norwegian University of Science and Technology (NTNU) in 2012. Sundan and his team focus on why cancer cells survive in the bone marrow in myeloma cases. In particular, they are interested in differences between cancer cells and normal cells at the DNA and protein level. The research group also investigates why some cancer cells are sensitive to treatment whereas others are resistant.
'Multiple Myeloma – clinical problem and cancer model' is his presentation for the Hans Prydz Guest Lecture series.
Krister Wennerberg is heading the Cancer Chemical Systems Biology Group at the Institute for Molecular Medicine Finland (FIMM), Nordic EMBL Partnership. His Research group is focused on gaining fundamental novel understanding of cancers and their phenotypes using a chemical systems biology approach. Bjørn Tore Gjertsen is Professor in hematology at the Department of Clinical Science at the University of Bergen. Wennerberg and Gjertsen will lecture on drug sensitivity testing and personalized medicine in leukemia.